Status:
COMPLETED
The Effect of a Fasting MimickINg Diet on the Immune System
Lead Sponsor:
Leiden University Medical Center
Conditions:
Healthy Subjects
Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Fasting or a Fasting Mimicking diet (FMD) can lower blood concentration of glucose and IGF1. Since cancer cells rely mostly on a glucose-based metabolism, FMD renders cancer cells more vulnerable to c...
Eligibility Criteria
Inclusion
- ≥18 years old
- BMI ≥18.5 and ≤25kg/m2
Exclusion
- Chronic disease or active infection
- Medication use other than contraceptive, during the last 12 weeks prior to inclusion.
- A history of allergy
- Blood or plasma donation in the last 12 weeks prior to inclusion.
- Participation in other medical research in the last 12 weeks prior to inclusion.
Key Trial Info
Start Date :
November 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 28 2022
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT04833439
Start Date
November 1 2021
End Date
April 28 2022
Last Update
July 27 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Leiden University Medical Center
Leiden, South Holland, Netherlands, 2333 ZA